According to its UK licence (SmPC), Saxenda is indicated for weight management in adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia
New Medicare GLP-1 Bridge program = weight loss medications for as little as $50/month for eligible patients
They sign up for the first provider they find, accept whatever price appears on screen, and never realize that identical medication costs 40% less somewhere else
Prdida rpida de peso y cambios metablicos: La tirzepatida puede producir una prdida de peso significativa, que en estudios clnicos como SURMOUNT-1 alcanz aproximadamente 15-22% del peso inicial con las dosis ms altas en personas sin diabetes (generalmente menor en pacientes con diabetes tipo 2)
Microdosing Tirzepatide Explained Microdosing tirzepatide means using 0.5-2.5 mg weekly instead of 5-15 mg
It is reported that LC increases GnRH secretion from the hypothalamus by acting on the HPG axis [16, 17] and causing K + -induced depolarization in hypothalamic neuronal cells to increase its secretory activity [80, 81]